Abstract
The accurate measurement of medication adherence is challenging, particularly in pediatrics. Electronic monitoring has been proposed as a possible “gold standard” for medication adherence measurement. Electronic monitoring permits the evaluation of patterns of medication use and dose-response relationship and may be a useful part of adherence promotion interventions. The use of these devices, however, is not without costs and cautions including, expense, malfunctioning, and interference with existing adherence routines. This review examines the costs and benefits of using electronic monitoring of adherence as well as the reliability and validity of electronic monitoring in general and, where possible, for specific devices (i.e., MEMS, MDIlog, and Doser). Finally, we provide recommendations for quality control protocols to minimize many of the problems encountered when using such devices. Ultimately, the choice of adherence measurement strategy should be based on the goal of the study and the resources available.
Similar content being viewed by others
REFERENCES
American Psychological Association. (1992). Ethical principles of psychologists and cod of conduct. American Psychologist, 47, 1597–1611.
Apter, A. J., Tor, M., & Feldman, H. I. (2001). Testing the reliability of old and new features of a new electronic monitor for metered dose inhalers. Annals of Allergy, Asthma, and Immunology, 86, 421–424.
Bachmann, L. H., Stephens, J., Richey, C. M., & Hook, E.W. (1999). Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes. Sexually Transmitted Diseases, 26, 272–277.
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366.
Bender, B., Wamboldt, F. S., O'Connor, S. L., Rand, C., Szefler, S., Milgrom H., et al. (2000). Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Annals of Allergy, Asthma, and Immunology, 85, 416–421.
Berg, J., Dunbar-Jacob, J., & Rohay, J. (1998). Compliance with inhaled medications: The relationship between diary and electronic monitor. Annals of Behavioral Medicine, 20, 36–38.
Blowey, D. L., Hébert, D., Arbus, G. S., Pool, R., Korus, M., & Koren, G. (1997). Compliance with cyclosporine in adolescent renal transplant recipients. Pediatric Nephrology, 11, 547–551.
Brueckner, J. W., Marshik, P., Sherman, J., & Hendeles, L. (1997). Reliability of the Medtrac MDI Chronolog. Journal of Allergy and Clinical Immunology, 100, 488–491.
Choo, P.W., Rand, C. S., Inui, T., Lee, M. L. T., Cain, E., Cordeiro-Breault, M., et al. (1999). Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Medical Care, 37, 846–857.
Cramer, J. A. (1995). Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs, 49, 597–605.
Fallab-Stubi, X. L., Zellweger, J. P., Sauty, A., Uldry, C., Iorillo, D., & Burnier, M. (1998). Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. International Journal of Tuberculosis and Lung Disease, 2, 525–530.
Farmer, K.C. (1999). Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics, 21, 1074–1090.
George, C. F., Peveler, R. C., & Thompson, C. (2000). Compliance with tricyclic antidepressants: The value of four different methods of assessment. British Journal of Clinical Pharmocology, 50, 166–171.
Gong, H., Simmons, M. S., Clark, V. A., & Tashkin, D. P. (1988). Metered-dose inhaler usage in subjects with asthma: Comparison of Nebulizer Chronolog and daily diary recordings. Journal of Allergy and Clinical Immunology, 82, 5–10.
Johnson, B. F., Gamilton, G., Fink, J., Lucey, G., Bennet, N., & Lew, R. (2000). A design for testing interventions to improve adherence within a hypertension clinical trial. Controlled Clinical Trials, 21, 62–72.
LaGreca, A.M.(1990). Issues in adherence with pediatric regimens, Journal of Pediatric Psychology, 15, 285–308.
Liu, H., Golin, C. E., Miller, L.G., Hays, R.D., Beck, K., Sanandaji, S., et al. (2001). A comparison study of multiple measures 34 Riekert and Rand of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 1004–1006.
Matsui, D., Hermann, C., Klein, J., Berkovitch, M., Olivieri, N., & Koren, G. (1994). Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. Journal of Clinical Pharmacology, 34, 944–949.
Milgrom, H., Bender, B., Ackerson, L., Bowry, P., Smity, B., & Rand, C. (1996). Noncompliance and treatment failure in children with asthma. Journal of Allergy and Clinical Immunology, 98, 1051–1057.
Paes, A.H. P., Bakker, A., & Soe-Agnie, C. J. (1998). Measurement of patient compliance. PharmacyWorld and Science, 20, 73–77.
Patterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.
Quittner, A. L., Espelage, D. L., Ievers-Landis, C., & Drotar, D. (2000). Measuring adherence to medical treatments in childhood chronic illness: Considering multiple methods and sources of information. Journal of Clinical Psychology in Medical Settings, 7, 41–54.
Rand, C. S., & Sevick, M. A. (2000). Ethics in adherence promotion and monitoring. Controlled Clinical Trials, 21, 241S–247S.
Rand, C. S., & Weeks, K. (1998). Measuring adherence with medication regimens in clinical care research. In S. A. Shumaker, E. Schron, J. Ockene, & W. McBee (Eds.), The handbook of health behavior change (2nd ed., pp. 114–132). New York: Springer.
Rand, C. S., & Wise, R. A. (1994). Measuring adherence to asthma mediation regimens. American Journal of Respiratory and Critical Care Medicine, 149, S69–S76.
Rand, C. S., Wise, R. A., Nides, M., Simmons, M. S., Bleecker, E. R., Kusek, J.W., et al. (1992). Metered-dose inhaler adherence in a clinical trial. American Review of Respiratory Disease, 146, 1559–1564.
Rapoff, M.A. (1999). Adherence to pediatric medical regimens. New York, NY: Kluwer Academic/Plenum Publishers.
Rivers, P. H., Ardagh-Walter, N., & Wright E. C. (1998). Measurement of anticonvulsant adherence behavior in the community using a medication events monitoring system (MEMS). Health Care Analysis, 6, 308–316.
Rudd, P. (1993). The measurement of compliance: Medication taking. In M.A. Krasnegor, L. Epstein, S. B. Johnson, & S. J. Yaffe (Eds.), Developmental aspects of health compliance behavior (pp. 185–213). Hillsdale, NJ: Erlbaum.
Schwed, A., Fallab, C. L., Burnier, M., Waeber, B., Kappenberger, L., Burnand, B., et al. (1999). Electronic monitoring of compliance to lipid-lowering therapy in clinical practice. Journal of Clinical Pharmacology, 39, 402–409.
Simmons, M. S., Nides, M. A., Kleerup, E., Chapman, K. R., Milgrom, H., Rand, C. S., et al. (1998). Validation of the Doser, a new device for monitoring meter-dose inhaler use. Journal of Allergy and Clinical Immunology, 102, 409–413.
Simmons, M. S., Nides, M. A., Rand, C. S., Wise, R. A., & Tashkin, D. P. (1996). Trends in compliance with bronchodilators inhaler use between follow-up visits in a clinical trial. Chest, 109, 963–968.
Steiner, J. F., & Proshazka, A. V. (1997). The assessment of refill compliance using pharmacy records: Methods, Validity, and applications. Journal of Clinical Epidemiology, 50, 105–116.
Straka, R. J., Fish, J. T., Benson, S. R., & Suh, J. T. (1997). Patient self-reporting of compliance does not correspond with electronic monitoring: An evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy, 17, 126–132.
Tashkin, D. P., Rand, C., Nides, M., Simmons, M., Wise, R., Coulson, A. H., et al. (1991). A Nebulizer Chronolog to monitor compliance with inhaler use. The American Journal of Medicine, 91, 4A-33S–4A-36S.
Urquhart, J. (1997). The electronic medication event monitor: Lessons for pharmacotherapy. Clinical Pharmacokinet, 32, 345–356.
Vijens, B., & Goetghebeur, E. (1997). Comparing compliance patterns between randomized treatments. Controlled Clinical Trials, 18, 187–203.
Wamboldt, F. S., Bender, B. G., O'Connor, S. L., Gavin, L. A., Wamboldt, M. Z., Milgrom, H., et al. (1999). Reliability of the model MC-311 MDI Chronolog. Journal of Allergy and Clinical Immunology, 104, 53–57.
Weeks, K., Rand, C., & Wise, R. (1997). Guidelines for interpreting metered dose inhaler (MDI) adherence with a thermistoractuatedMDIchronolog. American Journal of Respiratory and Critical Care Medine, 155(4), A310.
Weeks, K., Schweiger, D., Wise, R., & Rand, C. (1998). Accuracy of theMDIlog—A new electronic metered-dose inhaler monitor. Annalsof Behavioral Medicine, 20 (Suppl.), S223.
Williams, D. M., Wessell, A., & Brock, T. P. (1999). The Doser external counting device. Chest, 116, 1499.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riekert, K.A., Rand, C.S. Electronic Monitoring of Medication Adherence: When Is High-Tech Best?. Journal of Clinical Psychology in Medical Settings 9, 25–34 (2002). https://doi.org/10.1023/A:1014131928789
Issue Date:
DOI: https://doi.org/10.1023/A:1014131928789